Pay in 4 interest-free payments of $6.96 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Pathway / mechanism context BPC-157 is primarily associated with the modulation of nitric oxide synthase activity, vascular endothelial growth factor (VEGF) signaling, and regulation of inflammatory mediators, mediated by changes in gene expression rather than direct receptor agonism
In pre-clinical research, it is primarily studied for its effects on gastrointestinal healing, tendon and ligament repair, vascular growth (angiogenesis), and potential neuroprotective properties
Quality Guaranteed Every batch is manufactured to exact USP specifications, independently tested, with no compromises
Lower concentrations would push injection volumes uncomfortably high
Product Overview BPC-157 + TB-500 is a dual-peptide research formulation consisting of two synthetic laboratory peptides manufactured to analytical-grade specifications
Administration and Guidance BPC-157 is administered via subcutaneous injection, typically near the area of injury or concern
